Uneek Mehra
Finanzdirektor/CFO bei 4D MOLECULAR THERAPEUTICS, INC.
Vermögen: - $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Uneek Mehra
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 16 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Uneek Mehra
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
Ignite Immunotherapy, Inc.
 Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Biotechnology | Founder Founder | |
| CELGENE | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Founder Chief Tech/Sci/R&D Officer | |
| University of Oxford | College/University | Corporate Officer/Principal Graduate Degree | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Executive Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| MESOBLAST LIMITED | Biotechnology | Director/Board Member | |
| UROGEN PHARMA LTD. | Biotechnology | Director/Board Member | |
| CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| CENTREXION THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Shawn Tomasello Consulting LLC
 Shawn Tomasello Consulting LLC Miscellaneous Commercial ServicesCommercial Services Shawn Tomasello Consulting LLC provides business consulting services. The private company is based in Miramar Beach. The American company was founded by Shawn Cline Tomasello. | Miscellaneous Commercial Services | Chief Executive Officer | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Corporate Officer/Principal | |
| DIPLOMAT PHARMACY, INC. | Drugstore Chains | Director/Board Member | |
| University of Cincinnati (Ohio) | College/University | Undergraduate Degree | |
| Murray State University (Kentucky) | College/University | Masters Business Admin | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Chairman | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member | |
| University College London | College/University | Doctorate Degree | |
| The University of Southampton | College/University | Undergraduate Degree | |
| Macula Society | Corporate Officer/Principal | ||
RetroSense Therapeutics LLC
 RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Bright Peak Therapeutics, Inc.
 Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | Pharmaceuticals: Major | Chairman | |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Biotechnology | Chairman | |
Packard Children's Health Alliance
 Packard Children's Health Alliance Hospital/Nursing ManagementHealth Services Packard Children's Health Alliance operates a medical and surgical hospital for children. The private company is based in Palo Alto, CA. | Hospital/Nursing Management | Director/Board Member | |
TPG Capital LP
 TPG Capital LP Financial ConglomeratesFinance TPG Capital LP provides financial investment services. The company was founded by David Bonderman, William S. Price III and James George Coulter Jr. and is headquartered in Houston, TX. | Financial Conglomerates | Corporate Officer/Principal | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member | |
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA. | Biotechnology | Director/Board Member | |
| ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
| Miller-Rich Associates LLC | Chief Executive Officer | ||
| University of Pennsylvania | College/University | Graduate Degree | |
| University of Georgia | College/University | Doctorate Degree | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | General Counsel | |
Synthego Corp.
 Synthego Corp. BiotechnologyHealth Technology Synthego Corp. provides the game changing by integrating science, engineering and software. It designs and builds software and hardware solutions for building automated smart research facilities. The company was founded Michael Dabrowski and Paul Dabrowski in 2012 and is headquartered in Redwood City, CA. | Biotechnology | General Counsel | |
| American University | College/University | Doctorate Degree | |
| San Jose State University | College/University | Undergraduate Degree | |
| INTERMUNE INC | Biotechnology | Corporate Officer/Principal | |
| JUNO THERAPEUTICS INC | Biotechnology | Corporate Officer/Principal | |
| University of California, Santa Barbara | College/University | Undergraduate Degree | |
| SILLAJEN, INC. | Biotechnology | Corporate Officer/Principal | |
Helio Vision, Inc.
 Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
BioTheryX, Inc.
 BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Pharmaceuticals: Major | Chairman | |
TEN63 Therapeutics
 TEN63 Therapeutics Pharmaceuticals: MajorHealth Technology TEN63 Therapeutics provides drug development services. The American company was founded by Nancy Miller-Rich, Marcel Frenkel, Mark Hallen, Bruce Donald. Marcel Frenkel has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
| Envision Rx Options Holdings, Inc. | Director/Board Member | ||
Attralus, Inc.
 Attralus, Inc. Pharmaceuticals: MajorHealth Technology Attralus, Inc. operates as a biopharmaceutical company. The firm focuses on illuminating the systemic nature of amyloidosis and creating transformative medicines to improve the lives of patients. The company was founded by Jonathan Wall in 2019 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 43 |
| Vereinigtes Königreich | 5 |
| Australien | 2 |
| Kanada | 2 |
| Schweiz | 2 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 13 |
| Commercial Services | 4 |
| Retail Trade | 2 |
| Health Services | 2 |
Operativ
| Director/Board Member | 61 |
| Corporate Officer/Principal | 34 |
| Independent Dir/Board Member | 27 |
| Undergraduate Degree | 12 |
| Doctorate Degree | 11 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Shawn Tomasello | 22 |
| Susannah Gray | 20 |
| Jacob Chacko | 18 |
| Nancy Miller-Rich | 15 |
| David Kirn | 13 |
| August Moretti | 10 |
| John Milligan | 9 |
| Charles Theuer | 9 |
| Theresa Janke | 6 |
| Fariborz Kamal | 6 |
| Scott Bizily | 6 |
| Peter Francis | 5 |
| Noriyuki Kasahara | 3 |
| An Song | 1 |
| Julian Pei | 1 |
- Börse
- Insiders
- Uneek Mehra
- Unternehmensverbindungen
